{
    "2020-05-29": [
        [
            {
                "time": "2020-05-29",
                "original_text": "王晶翼获科伦千万股权激励，本土药企为留人才放大招！恒瑞、信达、基石……谁的激励更丰厚？",
                "features": {
                    "keywords": [
                        "股权激励",
                        "科伦",
                        "恒瑞",
                        "信达",
                        "基石"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-05-29",
                "original_text": "北上资金本周净买入152.45亿元，38股现身活跃股榜单",
                "features": {
                    "keywords": [
                        "北上资金",
                        "净买入",
                        "活跃股"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-05-29",
                "original_text": "1万年薪却能得9亿分红？299家A股药企高管薪酬大揭秘！迈瑞、药明争抢榜首，恒瑞仍保持低调",
                "features": {
                    "keywords": [
                        "高管薪酬",
                        "迈瑞",
                        "药明",
                        "恒瑞"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-05-29",
                "original_text": "石药集团欲登科创板：新药研发成本高，急拓A股输血渠道",
                "features": {
                    "keywords": [
                        "石药集团",
                        "科创板",
                        "新药研发",
                        "融资"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-05-29",
                "original_text": "政策鼓励加强公共卫生体系建设，短期关注三投资主线",
                "features": {
                    "keywords": [
                        "政策",
                        "公共卫生",
                        "投资主线"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "公共健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}